Check-Cap Stock Forecast, Price & News

-0.01 (-0.92 %)
(As of 07/27/2021 11:39 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume9,190 shs
Average Volume6.61 million shs
Market Capitalization$49.94 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CHEK News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

Check-Cap logo

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a disposable system attached to the patient's back via biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis and report generation. The company was founded in 2004 and is based in Isfiya, Israel.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.36 out of 5 stars

Medical Sector

835th out of 2,218 stocks

X-Ray Apparatus & Tubes Industry

2nd out of 5 stocks

Analyst Opinion: 3.3Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Check-Cap (NASDAQ:CHEK) Frequently Asked Questions

Is Check-Cap a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Check-Cap stock.
View analyst ratings for Check-Cap
or view top-rated stocks.

What stocks does MarketBeat like better than Check-Cap?

Wall Street analysts have given Check-Cap a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Check-Cap wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Check-Cap?

Check-Cap saw a increase in short interest in July. As of July 15th, there was short interest totaling 5,170,000 shares, an increase of 21.9% from the June 30th total of 4,240,000 shares. Based on an average daily trading volume, of 3,060,000 shares, the days-to-cover ratio is presently 1.7 days.
View Check-Cap's Short Interest

When is Check-Cap's next earnings date?

Check-Cap is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Check-Cap

How were Check-Cap's earnings last quarter?

Check-Cap Ltd. (NASDAQ:CHEK) released its earnings results on Wednesday, May, 12th. The medical research company reported ($0.05) EPS for the quarter, meeting the consensus estimate of ($0.05).
View Check-Cap's earnings history

How has Check-Cap's stock price been impacted by COVID-19?

Check-Cap's stock was trading at $1.32 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CHEK stock has decreased by 17.4% and is now trading at $1.09.
View which stocks have been most impacted by COVID-19

When did Check-Cap's stock split? How did Check-Cap's stock split work?

Check-Cap's stock reverse split on Wednesday, April 4th 2018. The 1-12 reverse split was announced on Wednesday, April 4th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 3rd 2018. An investor that had 100 shares of Check-Cap stock prior to the reverse split would have 8 shares after the split.

What price target have analysts set for CHEK?

2 Wall Street analysts have issued 12-month price objectives for Check-Cap's stock. Their forecasts range from $2.00 to $4.00. On average, they anticipate Check-Cap's stock price to reach $3.00 in the next year. This suggests a possible upside of 175.2% from the stock's current price.
View analysts' price targets for Check-Cap
or view top-rated stocks among Wall Street analysts.

Who are Check-Cap's key executives?

Check-Cap's management team includes the following people:
  • Mr. Alex Ovadia, CEO & Director (Age 59, Pay $493.56k)
  • Dr. Yoav Kimchy Ph.D., Founder & Chief Technology Officer (Age 60, Pay $473.54k)
  • Ms. Mira Rosenzweig, Chief Financial Officer (Age 49, Pay $291.36k)
  • Mr. Joshua Belkar, VP of Operations (Age 52, Pay $253.2k)

Who are some of Check-Cap's key competitors?

What other stocks do shareholders of Check-Cap own?

When did Check-Cap IPO?

(CHEK) raised $13 million in an IPO on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group served as the underwriters for the IPO and Feltl and Company was co-manager.

What is Check-Cap's stock symbol?

Check-Cap trades on the NASDAQ under the ticker symbol "CHEK."

How do I buy shares of Check-Cap?

Shares of CHEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Check-Cap's stock price today?

One share of CHEK stock can currently be purchased for approximately $1.09.

How much money does Check-Cap make?

Check-Cap has a market capitalization of $50.40 million. The medical research company earns $-13,850,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis.

How many employees does Check-Cap have?

Check-Cap employs 65 workers across the globe.

What is Check-Cap's official website?

The official website for Check-Cap is

Where are Check-Cap's headquarters?

Check-Cap is headquartered at 29 ABBA HUSHI AVE. P.O.BOX 1271, ISFIYA L3, 3009000.

How can I contact Check-Cap?

Check-Cap's mailing address is 29 ABBA HUSHI AVE. P.O.BOX 1271, ISFIYA L3, 3009000. The medical research company can be reached via phone at 972546706451 or via email at [email protected]

This page was last updated on 7/27/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.